Outcomes of Patients Initially Treated with Intravitreal Bevacizumab for Central Retinal Vein Occlusion: Long-Term Follow-Up
Sign Up to like & getrecommendations! Published in 2018 at "Seminars in Ophthalmology"
DOI: 10.1080/08820538.2016.1230637
Abstract: Dear Editor, We read with interest the article by Bajric and Bakri. The authors evaluated the outcomes of visual acuity (VA) and central retinal thickness (CRT) in patients with macular edema (ME) secondary to central… read more here.
Keywords: vein occlusion; initially treated; central retinal; intravitreal bevacizumab ... See more keywords
Characteristics and comorbidities of veterans treated with enzalutamide or abiraterone.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e17022
Abstract: e17022 Background: Prostate cancer (PCa) is the most common male malignancy and is the fourth leading cause of cancer-related death in males worldwide. Enzalutamide (ENZ) and Abiraterone (AA) are used in the treatment of castrate… read more here.
Keywords: patients treated; treated enz; treatment; characteristics comorbidities ... See more keywords